GARDASIL^®

Press Releases

May 31, 2011	Gardasil^® Approved To Help Prevent Anal Cancer In Women And Men
May 09, 2011	New Data Reinforces GARDASIL'S Safety Profile
Apr 26, 2011	Health Canada Approves Gardasil^® for Women Up to Age 45
Feb 2, 2011	New England Journal of Medicine Publishes Efficacy and Safety Data for Gardasil^® in Males
Feb 23, 2010	Gardasil^® Approved by Health Canada for Males to Prevent Genital Warts
Feb 17, 2010	Gardasil^® Helps Prevent Anal Cancer in Men, Showed New Study
May 8, 2009	Study shows HPV-16 Vaccine Demonstrated more than 8 Years of Protection Against Disease
Dec 11, 2008	Gardasil® Honored with a Prix Galien
Nov 13, 2008	New Study on Males Shows GARDASIL® Reduced HPV-Related Diseases
Oct 07, 2008	Merck Frosst Congratulates Nobel Laureate for Research Leading to Development of GARDASIL®
Oct 05, 2007	GARDASIL® may offer additional protection against 10 extra cancer-causing HPV types
Aug 20, 2007	Merck Frosst responds to Maclean's
Aug 17, 2007	GARDASIL®: The Facts Questions & Answers in Response to Maclean's Article
Aug 16, 2007	GARDASIL ad campaign for women
Aug 07, 2007	Study shows most parents want provincially-funded HPV vaccine right away
May 17, 2007	The Lancet publishes data showing GARDASIL™ protects against vulvar and vaginal cancers
May 10, 2007	New England Journal of Medicine publishes comprehensive data on GARDASIL™
Jan 30, 2007	Merck Frosst’s Gardasil™ now recommended by National Vaccine Advisory Committee
Dec 03, 2006	New Pan-Canadian Data on Burden of HPV-Related Diseases Presented at the 7th Canadian Immunization Conference (CIC)
Aug 21, 2006	Merck Frosst’s Gardasil™ Now Available In Canada
Apr 26, 2006	Merck’s Study of its Investigational HPV Vaccine on Previously Infected Women Reveals Positive Results
May 02, 2005	New Study Shows Merck’s Investigational Vaccine Against Human Papillomavirus - The World’s Most Common Sexually Transmitted Infection - Reduced Infection And Related Diseases